Share this video  

BTOG 2021 | Highlights from BTOG 2021

Alastair Greystoke, MBChB, MSc, PhD, MRCP, Northern Institute for Cancer Research, Newcastle University, Newcastle, UK, shares his highlights from the 19th British Thoracic Oncology Group (BTOG) Annual Conference 2021, commenting on the impacts of the COVID-19 pandemic.


Alastair Greystoke, MBChB, MSc, PhD, MRCP, has received consultancy and speaker fees from AstraZeneca, Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, Janssen/ J and J, Foundation Medicine, MSD, Novartis, Pfizer, Lilly, Takeda and Roche; and has received research funding from AstraZeneca.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter